Back to Search
Start Over
Effects of Chemical Modifications on siRNA Strand Selection in Mammalian Cells.
- Source :
-
Nucleic acid therapeutics [Nucleic Acid Ther] 2020 Aug; Vol. 30 (4), pp. 229-236. Date of Electronic Publication: 2020 Mar 12. - Publication Year :
- 2020
-
Abstract
- Small interfering RNAs (siRNAs) enable efficient gene silencing through RNA interference (RNAi) mechanisms. The RNAi machinery relies on an RNA-guided nuclease, Argonaute-2 (Ago2), which preferentially selects a single strand from an siRNA duplex. Complementarity between the selected strand and an RNA target strand leads to silencing through cleavage. The U.S. Food and Drug Administration's recent approval of two siRNA drugs has reignited optimism for RNAi therapeutics. Despite this recent success in the field, off-target effects are still a major concern; however, chemical modifications have shown promise in mitigating some off-target gene silencing. To evaluate the impact of novel chemical modifications on strand selection, we developed a quantitative polymerase chain reaction-based assay that is compatible with several pre-existing siRNA libraries and was used to characterize chemically modified siRNAs. siRNAs bearing azobenzene and propargyl modifications at the central region of the passenger strand significantly improved strand selection. On the other hand, folic acid-modified siRNAs improved strand selection best when placed at the 3' terminus. This study highlights the development and utility of a convenient method to evaluate the impact that novel chemical modifications have on strand-specific gene silencing of siRNAs.
- Subjects :
- Argonaute Proteins antagonists & inhibitors
Azo Compounds chemistry
Folic Acid chemistry
Folic Acid pharmacology
Gene Silencing drug effects
Humans
RNA Interference
RNA, Small Interfering pharmacology
United States
Argonaute Proteins genetics
RNA, Double-Stranded genetics
RNA, Small Interfering genetics
Subjects
Details
- Language :
- English
- ISSN :
- 2159-3345
- Volume :
- 30
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Nucleic acid therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 32175808
- Full Text :
- https://doi.org/10.1089/nat.2020.0848